ZD-526

N/A

Report date: 2026/01/14 20:00:44
NME

Base Information

Drug NameZD-526
Drug Alias NameZD526ZD-526
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCognitive DysfunctionAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHangzhou Zhihe Dangu Biopharmaceutical Co., Ltd.
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHangzhou Zhihe Dangu Biopharmaceutical Co., Ltd.
Inactive CompaniesN/A
Active IndicationsCognitive DysfunctionAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A